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Abstract 
Background: The use of both autograft as well as allograft tissue in anterior cruciate ligament 
reconstruction surgeries, performed by present day surgeons in patients of a wide age range, is 
prevalent. However, failure risks in such surgeries depend on a multitude of factors. In order to 
appropriately use the more suitable type of tissue in patients of ACL reconstruction surgeries, 
some of the main factors affecting failure risks are investigated. Procedures:  Extensive data 
regarding ACL reconstruction surgery patients was collected through MOON (Multi-Center 
Orthopedic Outcomes Network) patient questionnaires and surgeon forms. The data processing 
was completed in three parts. In the first part, the occurrence of re-tear in ACL reconstruction 
patients with allografts vs. those with autografts was determined as a binary outcome (tear/no 
tear). In addition, a logistic regression was done on any patient-associated factors that are related 
to incidence of re-tear. The second part of the study was focused on the evaluation of a 
dependent variable defined as “time to re-tear” in allograft ACL reconstructions, and 
investigating, using a Cox regression, its link to factors such as gender, age, and graft preparation 
criteria. Finally, the last part of the study is part of a survival analysis comparison between the 
time to re-tear of allografts and autografts (failure rates) in terms of the implications of factors 
such as the Marx score, gender and age. Outcome: Firstly, allograft reconstructions were 3.242 
times more likely to re-tear than autografts and the factors of age and graft type (auto/allo) 
significantly contributed to incidence of re-tear. Secondly, graft preparation factors showed no 
significant effect on the time to re-tear of allograft ACL reconstructions. Finally, in the third part 
of the study, the relative risk of re-tear in allograft reconstructions is 2.283 times higher than 
autograft ones with age affecting relative re-tear risk, while failure rates (times to re-tear) were 
similar between the two grafts. Conclusion: Generally, allografts have a higher risk of re-tear 
than autografts. In addition to that, age is a significant factor in affecting risk of re-tear. 
INTRODUCTION: 
 Anterior Cruciate Ligament reconstructions are common orthopedic surgeries in the 
young, athletic as well as older populations. Thousands of such surgeries are performed each 
year, with the majority of the surgeries completed with autograft tissue as opposed to allograft 
tissue. That is in part due to the fact that autogenous bone-patellar tendon-bone (BPTB) graft and 
the clinical results associated with it have been and remain to be the gold standard (S.K.Y. 
Chang et al, 2003).  
However, the use of allografts as an alternative to autografts in ACL reconstruction has 
been on the rise over the past few years. That is to overcome the problem of unavailability of 
patellar tendon autograft due to poor tissue quality (Schwartz et al, 2006) and the limited 
availability of autograft tissue to the width of the native patellar tendon (in BPTB grafts). There 
are also multiple potential complications associated with autografts that include patient donor 
site morbidity or patellofemoral arthrosis mentioned by Dr. Chang, et al. in a study by the 
University of Hawaii Orthopaedic Residency Program. 
 The main concern when conducting ACL reconstructions surgeries is the failure risks 
associated with the type of graft used. So far, there have been virtually no studies that directly 
compare the failure risks associated with autografts to those of allografts. However, a 
preliminary unpublished study done by the MOON group on 291 subjects the compared the risk 
of retear of allografts to that of autografts and found that patients who had an allograft 
reconstruction were 4.7 times more likely to retear than those who had autografts. The reason 
behind the presumed higher failure risks of allograft use is not quite known yet and could be 
affected by a multitude of factors. Such factors may be patient related such as age, gender or 
Marx score or they could be donor tissue related, specifically in the way the tissue was prepared 
by the tissue banks. It was found that age was a contributing factor to re-tear in the model created 
but Marx scores were not. However, a conjecture relating Marx scores and age is drawn, yet not 
tested. Also, surprisingly and against reports on tearing native ACLs, it was found that gender 
was not a factor related to retear risk.  
 Age of the patient undergoing surgery is often directly correlated with the activity level 
of the patient, hereby potentially influencing the probability of graft failure after surgeries. 
Higher graft failure risks have been shown to be more common in the younger / more active 
population in a study by the MOON group in 2007 in the unpublished study where it was 
determined that the younger patient had a 1.93 times higher risk of retear than a patient ten years 
older. However, such correlations do not simply imply causation and the relationship between 
the variables must be further proven. Knowing the relationship between the use of allografts and 
failure risks in certain age groups could be very useful when determining the graft type to be 
used in that age group. It is found that even though odds of retear are higher for allografts 
regardless of age, the model created showed an overall lower risk of retear for an older patient 
with an allograft. 
 The other category of factors potentially affecting allograft failure incidences is the tissue 
preparation specifics that may vary from one donor tissue bank to another. Valuable knowledge 
attained by examining the relationship between the preparation techniques and the failure risk of 
allografts could be used in deciding what type of tissue preparation from which donor bank will 
be best associated with high clinical success. This success would be demonstrated in the form of 
lower incidences and risk of re-tear. Disinfection or cleansing of the donor tissue using patented 
techniques such as Allowash is a preparation process aimed to eliminate any microbial presence 
on the tissue surface. It may be possible that such cleansing may have an effect on the 
biomechanics of the tissue and therefore ultimately an effect on its risk of failure; so such a 
factor is worth investigating. According to a study by Dr David Jones at the Mayo Clinic College 
of Medicine, the mechanical properties (tensile strength, cyclic creep) of allograft tissues treated 
with chemical disinfection are similar to the controls in the experiment that were untreated 
(Jones et al. 2007). This leads to the incumbent question of whether chemical treatment may 
affect the tissue post-implantation; in clinical cases. Therefore, the variable of chemical 
disinfection should be investigated in correlation with risk of retear.  
In addition to disinfection by chemicals, tissue banks commonly use gamma irradiation to 
sterilize the entire tissue as opposed to the surface only. A widely accepted dose of 2.5 Mrad or 
radiation is thought to have bactericidal and virucidal properties but significantly alters the initial 
biomechanical properties of soft tissue allograft (Rihn, Jeffrey A. et al, 2005). Such effects make 
no difference in clinical outcomes (incidences of retear) of surgeries as one study by Jeffrey A. 
Rihn at the University of Pittsburg School of Medicine shows, but are shown to possibly 
contribute to allograft failures in another study by Andrew R. Curran et al. that shows graft 
mechanical alteration in the form of cyclic elongation of the graft, associated with irradiation, 
that lowers the failure load for the tissue tested. (Curran at al. 2004) A possibility in the 
discrepancy between the studies could be that Rihn’s study was done one 102 patients (39 of 
which had allografts), a sample size too small to extrapolate results based on. Also, Curran’s 
study was not a clinical test of failure rates but a mechanical testing of the graft after treatment 
which may or may not have an effect on the clinical outcome of the surgery. As such, it is 
imperative that the factor of irradiation be considered in the model of factors affecting clinical 
outcomes of ACL reconstructions. 
 The purpose of this study is threefold. Firstly, a logistic regression was used to compare 
autografts to allografts in the incidence of failures as a binary outcome (retear / no-retear) and the 
effect of patient related characteristics, such as age, potentially associated with graft failures 
investigated. Secondly, the potential effect of allograft preparation techniques on the allograft 
failure risks is investigated through a survival analysis model. Finally, the survival analysis will 
also be used in the third part which attempts to compare relative retear risks of allografts to those 
of autografts (times to retear are compared) while evaluating patient related variables in the 
model. 
 The reason behind the central investigation is to attempt to provide enough knowledge 
for a surgeon to make a well-measured and justified choice of graft in an ACL reconstruction 
that would be most appropriate and well-suited to the demographic of a patient.  
PROCEDURE 
First, a comparison of the incidence of ACL reconstruction failures between the two 
types of graft was conducted through the statistical analysis of data collected by the MOON 
(Multicenter Orthopaedic Outcome Network) group of all subjects who underwent ACL 
reconstruction. The data subject group included patients who had their ACL reconstructions in 
between the years of 2002 to 2003. 
The data collected was in the form of patient surveys that included tests such as the Marx 
activity scores as well as extensive data relating to the demographic of the patient. There were 
two surveys collected, a pre-operative patient survey and one post operatively at 2 years from 
surgery. In addition to that, there were also surgeon surveys that collected detailed information 
regarding the patient injuries at the time of reconstruction surgery, that included basic data such 
as the graft type, source and the extent of injury (on MOON surgeon standardized scales) as well 
as other potentially relevant findings on the condition of other ligaments in the knee. Following a 
particular protocol of selection criteria, data obtained from 999 patients was used in the model 
predicting the incidence of ACL retears and the correlation between the aforementioned 
dependent variable and a multitude of factors such as graft type, age, gender, and Marx scores 
that could all potentially influence the outcome of the reconstruction surgery. 
 The primary outcome was a binary one with the only possibilities of tear or no tear 
(confirmed in patient phone calls as the incidence of a revision ACL reconstruction after the 
primary one within the period of 2 years). The factors, age, gender, Marx score and graft type, 
which may potentially influence the outcome, were each inserted in a logistic regression model 
using STATA 9.0, an application that performs statistical analyses. However, the correlation 
between the factors and the outcome was tested one factor at a time to bypass the issue of 
colinearity of the variables (variable interactions that may affect the outcome), and if found 
probably significant, was kept in the model. If not, the variable was dropped. Likelihood ratio 
tests comparing a model with all the variables and a model with the reduced variables were used 
to finish the model by dropping variables showing a test significance of lower than 0.05. In 
addition the surgeon performing the surgery was another variable considered and created to 
account for any ‘surgeon effect’ variable on the outcome of the reconstruction. The variables’ 
effect on the outcome could then be determined from the resultant model which only had factors 
that influenced the primary outcome. Statistical calculations on the model were collected. 
 In the subsequent part of the study, the one investigating graft preparation techniques and 
other factors and their potential effect on the failure risk of allografts, a survival analysis was 
done on 200 patients who received allografts. The type of allograft was controlled in all the 
patients and was a tibialis allograft. The subjects included in this part of the study were 
interviewed through phone and patient questionnaires to obtain data such as the incidence of re-
tear and time to re-tear. In addition, information including patient demographics (age and 
gender) as well as graft preparation techniques (use of irradiation or chemical disinfection) 
corresponding to the allograft used was obtained from the donor tissue banks that provided the 
graft. These risk factors potentially related to time of re-tear of allograft (determined by patient 
interviews/questionnaires) were tested via the survival analysis, specifically a Cox regression. 
Much like in the first model, the variables related to graft preparation (Chemical treatment, 
irradiation) and those patient-related (age) were tested one at a time to determine any significant 
effect on the time to failure. The variables showing significance were used to perform another 
likelihood ratio test which provided an improved model with no variables that had lower 
significance than 0.05. Statistical data was collected on the variables and the model. 
 Similarly, the final primary outcome in this study, time to re-tear of graft between 
autografts and allografts, was investigated using the survival analysis method of Cox regression 
models. Data was collected from patients in the same year range (2002-2003) whose graft 
(allograft or autograft) failed. The data collected was both patient and surgeon (surgery) related 
through the same questionnaires and survey method previously used; and all variables that may 
potentially have an impact on the primary outcome were tested in a similar model format to the 
one used in the previous part of the study. Again, statistically relevant data was collected on the 
variables and their correlation with the primary outcome. 
 
 
RESULTS  
The patient demographic data surveyed and collected was tabulated in table 1. Averages 
and deviations were calculated on certain demographic data and included in table 2. The logistic 
regression model constructed included all the variables from tables 1 and 2 and tested the effect 
of each variable on the outcome of surgery (odds of re-tear) through a Likelihood Ratio (LR) test 
which compared a model with all the variables included towards the outcome with the model that 
had reduced variables. The outcome was that graft type and age were the significant factors 
influencing incidences of re-tear yet, there was no significant interaction between the type of 
graft used and age. Also none of the variables tested, were found to significantly influence the 
model constructed. Table 3 contains all the odds ratios for variables predicting re-tear while 
controlling for the ‘surgeon effect’. The odds of re-tear are 3.242 times higher for a patient with 
an allograft reconstruction with control of age and the surgeon effect. (Without control of 
surgeon effect the number rises to 3.730) In addition to that, for a subject ten years younger, the 
risk of re-tear is 2.253 times higher, meaning that statistically speaking, age is a significant 
predictor of re-tear in ACL reconstruction regardless of graft type. For the age variable 
correlation, the surgeon effect variable had no impact unlike the graft type. 
Further evaluation of the model was performed through a construction of an ROC graph 
(Receiver-operating characteristic) where the area under the curve was greater than 0.7 at 0.7287 
(Figure 1.), meaning that the model’s prediction of re-tear based on the variables in the model is 
adequate. 
The second phase of analyses which revolved around investigating factors that lead to 
allograft re-tear included 359 patients who underwent allograft based ACL reconstructions and 
subsequently either re-tore or did not tear the graft. The factors, tissue treatment variables, tested 
were the use of Allowash and the use of gamma irradiation. Using a Kaplan Meier survival 
analysis, the tissue treatment factors were not found to have any significant influence on the 
clinic failure rate of the allograft; since the survival curve is always higher than 0.75 making it 
difficult to find any correlation between tissue treatment and re-tear risk insignificant. 
Concerning the final portion of the study which investigated relative time to re-tear 
(clinical failure) between allograft based ACL reconstructions and autograft based ones, a cox 
regression was performed on 38 patients who re-tore their graft in a group of 990 patients who 
had ACL reconstructions. Like in the first part, different variables (age and graft type) were 
tested in the model while accounting for the surgeon variable. The outcome was a higher relative 
risk of re-tear for a patient with an allograft by 2.283 times than a patient with an autograft at a 
constant age. Moreover, a subject 10 years younger than another had a relative risk 2.410 times 
higher than the latter regardless of graft type. Both hazard ratios account for the surgeon effect 
and are tabulated in table 4, along with the ratios with before accounting for the effect. Similarly 
to the first part results, the surgeon effect does not influence the hazard ratio of the age variable 
and when accounted for, decreases the hazard ratio for the graft variable. The overall model was 
deemed plausible by testing Cox-Snell residuals. 
Additionally, the mean time to graft failure was calculated and tabulated in table 5, to 
show that the mean times for autografts and allografts to retear were similar. This means that the 
rates of retear for both were shown to be similar. 
 
 
 
  
Table 1. Patient Demographic Distribution 
 
 
Male Female 
Gender 568, 57%  431, 43%  
Autograft Allograft 
Type of Graft 739, 74%  260, 26%  
No tear Tear 
Tear 952, 95%  47, 5%  
Primary Revision 
Primary or 
Revision 898, 90%  101, 10%  
 
 
Table 2. Averages for Demographic Data 
 
 Mean sd 
Age (Years) 26.82 10.8 
Height (in.) 68.56 5.08 
Weight (Ibs) 173.47 42.36 
Marx (points) 11.07 5.33 
 
Table 3. Variable risk ratio for re‐tear 
 
 
Variable Odds/Risk ratio 
Odds/Risk ratio (Not accounting for 
Surgeon Effect) 
Graft Type 
(Allo) 3.242 3.73 
Age (10 year 
increments) 0.922 0.922 
 
 
Table 4. Variable hazard ratio for relative risk to retear 
 
Variable Hazard ratio 
Hazard ratio (Not accounting for 
Surgeon Effect) 
Graft 
(Allograft) 2.283 2.788 
Age (10 year 
increments) 
0.916 
 
0.916 
 
 
Table 5. Average time to graft failure 
 
  Average time to 
retear 
Standard Deviation  Number of Subjects 
Autograft  12.57  5.57  23 
Allograft  13.13  6.55  15 
 
 
 
 DISCUSSION 
 The statistical analyses done on the cohorts of patients surveyed by the MOON group 
lead to a few statistically significant conclusions about variables affecting the outcome of an 
ACL reconstruction surgery.  
Firstly, the type of graft used affected both the incidence of re-tear and the odds of re-tear 
to time. Allografts were 3.242 times more likely to re-tear than autografts and had a higher 
relative risk of re-tear by a factor of 2.283. Secondly, the age variable proved to influence the 
incidence of re-tear as well as the relative risk of re-tear. Subjects younger by ten years were 
2.253 times more likely to re-tear and had a relative risk of re-tear 2.410 times higher than those 
ten years older. Although this significant correlation may mean that age affects the clinical 
outcome of ACL reconstructions, we hypothesize that age and activity levels are related which 
maybe the reason that age is an important factor for the trend in outcomes but there are 
insufficient studies that investigate this correlation in the literature. In addition to age exhibiting 
a correlation with clinical outcome, Marx scores were also tested but found insignificant, yet we 
also hypothesize that age and Marx scores may be related. This relationship was not tested, and 
Marx scores did not provide any additional information. 
Tissue preparation techniques in the form of chemical treatment such as allowash were 
found to be insignificant predictors of failure in allograft ACL reconstructions. This means that 
clinically, the chemically treated graft performs as well as the non-treated graft. The conclusion 
seems to concur with the conclusions in the Mayo Clinic study that indicate that chemically 
treated tissue mechanics are not altered by the chemical treatment. 
Our study also showed no significance in gamma irradiation techniques that sterilize 
tissue in predicting re-tear. The interpretation is that clinically, failure risks are not significantly 
different for allograft tissue that is irradiated as opposed to non-irradiated. The findings seem to 
contradict the study by Curran which showed adverse effects of irradiation on the mechanical 
properties of the issue pre-operatively, yet, it is evident in our and Rihn’s study, that clinical 
failure risks are no different than in untreated tissue. Further studies linking the correlation of 
mechanical properties of the tissue (failure loads) with clinical failures would be very helpful in 
reaching further conclusions.  
Additionally, the rates of retear for autografts and allografts (based on time to retear) 
were similar. This comes contrary to studies that have shown allografts to take a longer period of 
time to biologically incorporate than autograft tissue, leading to an expectation of larger failure 
rates for allografts in clinical cases. Such a study is done by the Southern California Center for 
Sports Medicine showing that autografts demonstrate a more “robust” response of incorporation 
six months post-operatively linked with increased strength to failure values (Tension 
mechanically applied before tear of graft). (Jackson et al., 1993). However this study is done in 
goats, not humans, and the incorporation rate is only linked to mechanical testing results and not 
clinical failure risks. A study linking human ACL reconstruction failure risks and incorporation 
rate is not available but would contribute significantly to the conclusions reached. 
Although the statistical conclusions based on strong correlations point to autografts being 
a ‘safer’ choice between the two grafts in promoting a lower risk of re-tear, the data set of 
patients that re-tore their ACL graft may have been too small to provide a strong and 
comprehensive investigation. In addition, the subset of patients that were considered old in age 
was small in the data population used and may not be sufficient to powerfully extrapolate and 
generalize trends in a bigger population from a statistical viewpoint. Moreover, it would be 
worthwhile investigating other allograft preparation techniques such as storage (freeze 
dried/fresh frozen) that may potentially affect the clinical success rate associated with the 
allograft used. 
 Nonetheless, the deduced statistical linkage between variables affecting clinical 
outcomes of ACL reconstructions serves as a reference of caution for surgeons deciding between 
allograft or autograft use in routine ACL surgeries, especially in younger populations who are at 
a statistically higher risk of ACL graft re-tear. 
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